These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1680726

  • 1. Clinical relevance of immunological markers in Graves' disease.
    Mann K, Saller B, Hörmann R.
    Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
    [No Abstract] [Full Text] [Related]

  • 2. Autoantibodies to the TSH receptor.
    Zakarija M, McKenzie JM.
    Exp Clin Endocrinol; 1991 May; 97(2-3):165-9. PubMed ID: 1680725
    [No Abstract] [Full Text] [Related]

  • 3. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM, Krenning EP, Docter R, Benner R, Hennemann G.
    Neth J Med; 1985 May; 28(1):32-9. PubMed ID: 2858065
    [No Abstract] [Full Text] [Related]

  • 4. TSH-receptor antibodies in hypothyroid Graves' disease.
    Konishi J, Kasagi K, Hidaka A, Takeuchi R, Iida Y, Nakamura H.
    Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y, Li C, Takagi J, Gotoh M, Habu S, Yasaka-Nomura T, Ishihara R, Nakasone Y, Nakamura R, Morikawa R, Otake K, Nogimori T, Ishizuki Y.
    Int J Clin Pharmacol Res; 2004 May; 24(4):111-6. PubMed ID: 15754915
    [Abstract] [Full Text] [Related]

  • 6. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K, Leövey A, Hauck M, Szabo J, Bako G.
    Radiobiol Radiother (Berl); 1987 May; 28(5):576-9. PubMed ID: 2894705
    [No Abstract] [Full Text] [Related]

  • 7. [Current topics on immunological laboratory tests-thyroid diseases].
    Iwatani Y.
    Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
    [Abstract] [Full Text] [Related]

  • 8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P, Harrison LC.
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [Abstract] [Full Text] [Related]

  • 9. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG, Hodak K, Seissler J, Steinbrenner H, Pampel I, Gupta M, McGregor AM, Scherbaum WA, Banga JP.
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [Abstract] [Full Text] [Related]

  • 10. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
    Kimura T, Okamoto Y.
    Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
    [Abstract] [Full Text] [Related]

  • 11. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR.
    J Cell Biochem; 1986 Nov; 31(2):107-20. PubMed ID: 2426288
    [Abstract] [Full Text] [Related]

  • 12. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Wien Klin Wochenschr; 1992 Nov; 104(24):744-7. PubMed ID: 1363165
    [Abstract] [Full Text] [Related]

  • 13. [The immune and nonimmune genesis of goiter].
    Grigorie D.
    Endocrinologie; 1990 Nov; 28(3-4):95-106. PubMed ID: 1983320
    [No Abstract] [Full Text] [Related]

  • 14. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [Abstract] [Full Text] [Related]

  • 15. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M, Schatz H, Bolle B, Pohl A, Meyer K.
    Exp Clin Endocrinol; 1992 Dec; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract] [Full Text] [Related]

  • 16. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK.
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [Abstract] [Full Text] [Related]

  • 17. Graves' disease: xenotransplantation model (athymic nude mice).
    Rippegather K, Schumm-Draeger PM, Usadel KH.
    Exp Clin Endocrinol Diabetes; 1996 Jun; 104 Suppl 3():34-6; discussion 36-7. PubMed ID: 8986419
    [No Abstract] [Full Text] [Related]

  • 18. The relationship of thyroid antibodies to the postpartum recurrence of hyperthyroidism in Graves' disease.
    Chang TC, Chen FW, Tsai WY, Chen SH, Chang CC, Yu TK, Chen YP, Liaw KY.
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):171-7. PubMed ID: 2883249
    [No Abstract] [Full Text] [Related]

  • 19. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R, McKillop JH, Pearson C, Burnett AK, Gunn I, McNicol AM, Thomson JA.
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [Abstract] [Full Text] [Related]

  • 20. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ, Bierwolf B, Kuhlmann E, Klugmann T, Dietel P, Fischer S.
    Dtsch Z Verdau Stoffwechselkr; 1987 Aug; 47(6):331-6. PubMed ID: 2896115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.